Login

Bruntwood set for AstraZeneca Cheshire campus win

Bruntwood alongside the Greater Manchester Pension Fund has been picked as preferred developer for a major redevelopment of AstraZeneca’s long-term R&D facility at Alderley Park in Tatton in Cheshire.
CoStar News
January 28, 2014 | 5:25 P.M.

The UK's second-biggest pharmaceutical company announced last year that it was closing down the facility with the loss of 550 jobs there and 150 elsewhere in the UK over the next three years.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In